Dr. Jeffrey Shaman is the Chief Science Officer at Coriell Life Sciences where his expertise in genetics, pharmacology, stem cells, and clinical laboratory operations is used to develop and promote genetic and medication risk reporting tools for healthcare professionals and patients. He held a faculty position at the University of Hawai‘i Institute of Biogenesis Research before moving to Harvard Medical School, Beth Israel Deaconess Medical Center, and the Bedford Stem Cell Research Foundation, where he bridged the gap between research and medicine thru genetic and clinical medicine initiatives. Dr. Shaman was recruited to Coriell Life Sciences from an international DNA sequencing provider, where he established Translational Genomics activities as a revenue-rich market vertical providing regulatory (FDA) and clinical (CLIA/CAP) services to international pharmaceutical companies, healthcare providers, physicians, and patients. He continues to lecture and publish on topics including pharmacogenomics, bioethics, and clinical care.

Stuart Sutley started his career with a four-year-tour in the United States Marine Corps as an infantry officer culminating in a strategic battalion position during Operation Desert Storm. Upon departing the Marine Corps as a decorated combat veteran, he embarked on a five-year sales and operations opportunity with consumer products giant Newell-Rubbermaid Corporation, and concurrently earned his MBA from Capital University in Columbus, Ohio. In 2001 Stuart started a corporate wellness company working with large employers across the country developing invaluable insight into health engagement strategies for employees and dependents. Seeing the opportunity to assist Academic Medical Centers in developing new revenue streams in the wellness and health management field led Stuart to lead the sales and business development efforts for Johns Hopkins HealthCare Solutions whose mission is to bring faculty-inspired discoveries to the large employer market.

Dr. Wohlgemuth oversees R&D, Medical, Employee Health and Employer Health and Wellness for Quest Diagnostics and is a member of the senior management team. Prior to joining Quest Diagnostics Dr. Wohlgemuth held the position of Director of Clinical Diagnostics, Immunology, Tissue Growth and Repair at Genentech as well as Global Development Team Leader – Ocrulizumab. He was co-founder and Chief Medical Officer for the molecular diagnostics company XDx, where he was awarded Technology Pioneer 2005 at the World Economic Forum in Davos. He is on the Board of Directors of the Personalized Medicine Coalition, Q2 Solutions and Diagnostic Labs of Oklahoma and serves as trustee of the Anne and Henry Zarrow Foundation, a charitable foundation focused on supporting delivering health care and social services.

Dr. Galante is the Chief Medical Officer with the Access Experience Team at PrecisionValue. He has over 30 years of experience in the healthcare industry and an extensive career in managed care, including population-based behavioral modification research with the application of computer-assisted instruction technology. Prior to joining PrecisionValue in 2013, he spent 16 years working at MVP Health Care, a regional health plan licensed in three states with 750,000 members across all lines of business, in numerous medical executive roles, including the Senior Medical Director/Corporate Vice President of Medical Quality Management. In this role, Dominic managed the strategic development and implementation of commercial and government programs and quality improvement program development and administration, including credentialing, peer review, patient clinical outcomes improvement, member complaint resolution, quality assurance, physician performance monitoring, reporting, improvement and P4P programs, performance/outcomes driven care delivery models (i.e., PCMH; ACO; IDN), value-based contracting and reimbursement models (Hospitals; SNF; LTC; Home Health; etc.) physician lead/clinical liaison for key employer accounts (such as Kodak, IBM, Xerox, Paychex, UAW, State and Federal Employees, etc.), National Committee for Quality Assurance (NCQA) accreditation, NCQA Healthcare Effectiveness Data and Information Set (HEDIS) performance improvement, primary care practice transformation, Accountable Care Organization performance improvement, and health insurance exchanges implementation.